The agency is missing deadlines and not responding to biotech companies, forcing some to push back clinical trials.

Clinical results of a GLP-1 in pill form showed safety and efficacy data similar to blockbuster injectable drugs.

Drugmaker Eli Lilly said Thursday that an experimental pill form of popular GLP-1 medications helped people with type 2 ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

The president said he would build on the Medicare drug-price negotiation program begun under Joe Biden, but supports a change ...

In his first major action on health care costs this term, President Donald Trump issued a multi-part executive order on ...

The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic, a drug to ...

A new executive order signed Tuesday by President Trump directs Congress to change a key provision of the law allowing ...

US President Donald Trump signed an executive order Tuesday aiming to lower crippling drug prices by giving states more ...

The nation’s health secretary addressed agency employees, asking them to shed any corporate influence. But he did not address ...

The Food and Drug Administration is reversing course on its requirement for all staffers to report to the office ...

The U.S. Food and Drug Administration is replacing animal testing with human-relevant methods, including artificial ...